.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Recent breakthroughs in medical technology have introduced biodegradable microrobots cardiac delivery systems that can navigate complex biological surfaces with high precision. These magnetically driven tools offer a fuel-free way to perform targeted medical tasks. Consequently, they represent a significant step forward for interventional cardiology and diagnostics.
The research team synthesized spherical microparticles using Poly (lactic-co-glycolic acid), commonly known as PLGA. They then applied a thin iron coating to one side of these spheres. This Janus-like design allows the particles to respond to rotating magnetic fields. Under these fields, the robots exhibit active rolling motion. Furthermore, the researchers utilized both manual and automated control systems to guide their movement accurately.
The study tested these microrobots on ex vivo chicken heart tissue. Despite the rough and heterogeneous surface of the tissue, the robots maintained consistent trajectory tracking. Additionally, the robots demonstrated a remarkable ability to transport living cells to specific targets. Because PLGA is naturally biocompatible, these robots degrade safely over time without causing significant cytotoxicity. Therefore, they address the critical challenge of leaving harmful residues in the body after a procedure.
These findings suggest that such microrobotic platforms could revolutionize in vivo diagnostics. They provide a versatile method for localized therapy while ensuring patient safety through their biodegradable nature. Future applications might include the precise delivery of drugs or stem cells to damaged heart areas.
They use an external rotating magnetic field to initiate a rolling motion. This allows them to traverse rough biological surfaces like heart tissue with high precision.
The robots are made from PLGA, a biocompatible and biodegradable polymer. They naturally break down in the body after completing their task, leaving no toxic residue.
Yes, the study confirmed that these microrobots can transport cells and potentially therapeutic agents to targeted locations on the tissue surface.
Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always seek the advice of a qualified healthcare provider with any questions regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
1. Kirmizitas FC et al. Biodegradable Microrobots for Active Navigation and Delivery on Ex Vivo Cardiac Models. Adv Healthc Mater. 2026 May 10. doi: 10.1002/adhm.202504779. PMID: 42106937.
2. Glotzer S. et al. Microrobots for targeted drug delivery. Science Advances. 2025 Jul 31.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
Researchers have developed biodegradable PLGA microrobots that use magnetic fields to navigate cardiac tissue for precise therapeutic delivery and diagnosti...
4 months ago
A new study reveals that lipid-related metabolic dysregulation, marked by elevated TG/HDL-C ratio and glymphatic changes, independently impacts survival in idiopathic normal pressure hydrocephalus.
Today
A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today
A meta-analysis of 13 propensity score-matched studies shows ViV-TAVR delivers lower early mortality and reduced bleeding compared to redo-SAVR for degenerated bioprosthetic aortic valves, though long-term hemodynamics warrant careful anatomical and patient-centered evaluation.
Today
Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday
The All-India Food Processors' Association has approached the Supreme Court to oppose FSSAI's proposed per-100g benchmark for front-of-pack warning labels, advocating instead for a per-serving threshold. We explore the regulatory showdown, nutritional evidence, and implications for clinical lifestyle counseling.
Today
